Nason, Yeager, Gerson, White & Lioce, P.A. represented Pittsburg, California based Biozone Pharmaceuticals, Inc. [publicly-traded California based company] in the sale of all of its operating assets and in the acquisition of a Seattle, Washington area biotechnology company. Both transactions closed January 2, 2014.
Securities and corporate shareholder, Michael D. Harris, led both transactions, assisted by shareholders Mark A. Pachman (corporate), George E. Harding (tax) and associate Beth Patterson Crews.
Biozone sold the assets of two subsidiaries including Biozone Laboratories, Inc., a specialty pharmaceutical manufacturer, to Musclepharm Corp., a Denver, Colorado based company in exchange for 1,200,000 shares of MusclePharm common stock. It immediately merged with Cocrystal Discovery, Inc., a biotechnology company.